Integrity^® bare-metal coronary stent-induced platelet and endothelial cell activation results in a higher risk of restenosis compared to Xience^® everolimus-eluting stents in stable angina patients

References

• Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O’Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315–1323.
   PubMed Web of Science ®Google Scholar
• Colombo A, Iakovou I. Drug-eluting stents: The new gold standard for percutaneous coronary revascularisation. Eur Heart J 2004;25:895–897.
   PubMed Web of Science ®Google Scholar
• Ramcharitar S, Hochadel M, Gaster AL, Onuma Y, Gitt A, Serruys PW. An insight into the current use of drug eluting stents in acute and elective percutaneous coronary interventions in Europe. A report on the EuroPCI Survey. EuroIntervention 2008;3:429–441.
   PubMedGoogle Scholar
• Patel MR, Pfisterer ME, Betriu A, Widmisky P, Holmes DR Jr, O’Neill WW, Stebbins A, Van de Werf F, Armstrong PW, Granger CB, et al. Comparison of six-month outcomes for primary percutaneous revascularization for acute myocardial infarction with drug-eluting versus bare metal stents (from the APEX-AMI study). Am J Cardiol 2009;103:181–186.
   PubMed Web of Science ®Google Scholar
• Claessen BE, Caixeta A, Henriques JP, Piek JJ. Current status of the Xience V® everolimus-eluting coronary stent system. Expert Rev Cardiovasc Ther 2010;8:1363–1374.
   PubMedGoogle Scholar
• De Felice F, Fiorilli R, Parma A, Musto C, Nazzaro MS, Stefanini GG, Caferri G, Violini R. Comparison of one-year cardiac events with drug-eluting versus bare metal stent implantation in rescue coronary angioplasty. Am J Cardiol 2011;107:210–214.
   PubMed Web of Science ®Google Scholar
• Fauchier L, Pellegrin C, Bernard A, Clementy N, Angoulvant D, Lip GY, Babuty D. Comparison of frequency of major adverse events in patients with atrial fibrillation receiving bare-metal versus drug-eluting stents in their coronary arteries. Am J Cardiol 2012;110:7–12.
   PubMed Web of Science ®Google Scholar
• Horst B, Rihal CS, Holmes DR Jr, Bresnahan JF, Prasad A, Gau G, Lennon R, Lerman A. Comparison of drug-eluting and bare-metal stents for stable coronary artery disease. JACC Cardiovasc Interventions 2009;2:321–328.
   PubMed Web of Science ®Google Scholar
• Groeneveld PW, Matta MA, Greenhut AP, Yang F. Drug-eluting compared with bare-metal coronary stents among elderly patients. J Am Coll Cardiol 2008;51:2017–2024.
   PubMed Web of Science ®Google Scholar
• Ielasi A, Brugaletta S, Silvestro A, Cequier A, Iñiguez A, Serra A, Hernandez-Antolin R, Mainar V, Valgimigli M, den Heijer P, et al. Everolimus-eluting stent versus bare-metal stent in elderly (≥75 years) versus non-elderly (<75 years) patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: insights from the examination trial. Int J Cardiol 2015;179:73–78.
   PubMed Web of Science ®Google Scholar
• Uthamalingam S, Ahmado I, Selvaraj V, Dewey R, Flynn J. Long term outcomes in octogenarians undergoing percutaneous coronary intervention: Comparison of bare metal versus drug eluting stent. Int J Cardiol 2015;179:385–389.
   PubMed Web of Science ®Google Scholar
• Applegate RJ, Sacrinty MT, Kutcher MA, Baki TT, Gandhi SK, Santos RM, Little WC. Comparison of drug-eluting versus bare metal stents on later frequency of acute myocardial infarction and death. Am J Cardiol 2007;99:333–338.
   PubMed Web of Science ®Google Scholar
• De Luca G, Dirksen MT, Spaulding C, Kelbaek H, Schalij M, Thuesen L, van der Hoeven B, Vink MA, Kaiser C, Musto C, et al. Drug-eluting vs bare-metal stents in primary angioplasty: A pooled patient-level meta-analysis of randomized trials. Arch Intern Med 2012;172:611–621.
   PubMedGoogle Scholar
• Gordon PC, Cohen DJ, Kleiman NS, Montgomery JA, Semder CA, Kennedy KF, Keyes MJ, Piana RN, EVENT Investigators. In-hospital and one year outcomes with drug-eluting versus bare metal stents in large native coronary arteries: A report from the evaluation of drug eluting stents and ischemic events registry. Catheter Cardiovasc Interventions 2013;82:356–364.
   Web of Science ®Google Scholar
• Gilis-Siek N, Fijalkowski M, Jaguszewski M, Targonski R, Strozyk A, Cackowska M, Masiewicz E, Skarzynski P, Burakowski S, Chmielecki M, et al. Major adverse cardiovascular events after drug-eluting stent implantation in patients with single chronic total occlusion: A single-center registry. J Invasive Cardiol 2013;25:567–572.
   PubMed Web of Science ®Google Scholar
• Mahemuti A, Meneveau N, Seronde MF, Schiele F, Descotes-Genon V, Ecarnot F, Blonde MC, Mercier M, Racadot E, Bassand JP. Early changes in local hemostasis activation following percutaneous coronary intervention in stable angina patients: A comparison between drug-eluting and bare metal stents. J Thromb Thrombol 2009;28:333–341.
   PubMed Web of Science ®Google Scholar
• 2013 ESC guidelines on the management of stable coronary artery disease. The Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 2013;34:2949–3003.
   Google Scholar
• 2014 ESC/EACTS Guidelines on myocardial revascularization. The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions. Eur Heart J 2014;35:2541–2619.
   Google Scholar
• Sheehy A, Hsu S, Sinn I, Tai J, Kolodgie FD, Nakazawa G, Yazdani SK, Quee SC, Virmani R, Polyakov I. Vascular response to coronary artery stenting in mature and juvenile swine. Cardiovasc Revasc Med 2011;12:375–384.
   PubMedGoogle Scholar
• Gibson CM, Karmpaliotis D, Kosmidou I, Murphy SA, Kirtane AJ, Budiu D, Ray KK, Herrmann HC, Lakkis N, Kovach R, et al. Comparison of effects of bare metal versus drug-eluting stent implantation on biomarker levels following percutaneous coronary intervention for non-ST-elevation acute coronary syndrome. Am J Cardiol 2006;97:1473–1477.
   PubMed Web of Science ®Google Scholar
• Mahemuti A, Meneveau N, Seronde MF, Schiele F, Mercier M, Racadot E, Bassand JP. Early local intracoronary platelet activation after drug-eluting stent placement. Chin Med J (Engl) 2007;120:1986–1991.
   PubMed Web of Science ®Google Scholar
• Mizia-Stec K, Gasior Z, Haberka M, Mizia M, Chmiel A, Janowska J, Holecki M, Mielczarek M, Zahorska-Markiewicz B. In-stent coronary restenosis, but not the type of stent, is associated with impaired endothelial-dependent vasodilatation. Kardiol Pol 2009;67:9–17.
   PubMed Web of Science ®Google Scholar
• Munk PS, Breland UM, Aukrust P, Skadberg O, Ueland T, Larsen AI. Inflammatory response to percutaneous coronary intervention in stable coronary artery disease. J Thromb Thrombol 2011;31:92–98.
   PubMed Web of Science ®Google Scholar
• Szük T, Nagy B Jr, Bereczky Z, Kőszegi Z, Édes I, Kappelmayer J. Effects of ad hoc clopidogrel loading versus pre-treatment on P-selectin expression after coronary stent implantation. Platelets 2006;17:344–346.
   PubMed Web of Science ®Google Scholar
• Bagoly Z, Sarkady F, Magyar T, Kappelmayer J, Pongrácz E, Csiba L, Muszbek L. Comparison of a new P2Y12 receptor specific platelet aggregation test with other laboratory methods in stroke patients on clopidogrel monotherapy. PLoS One 2013;8:e69417.
   PubMed Web of Science ®Google Scholar
• Nagy B Jr, Szük T, Debreceni IB, Kappelmayer J. Platelet-derived microparticle levels are significantly elevated in patients treated by elective stenting compared to subjects with diagnostic catheterization alone. Platelets 2010;21:147–151.
   PubMed Web of Science ®Google Scholar
• Kozinski M, Kubica J, Sukiennik A, Zbikowska-Gotz M, Krzewina-Kowalska A, Radomski M, Rychter M, Bialoszynski T, Jablonski M, Demidowicz K, et al. Periprocedural soluble P- and E-selectin levels fail as predictors of clinical restenosis in patients treated with elective coronary stenting. Int J Mol Med 2007;19:187–195.
   PubMed Web of Science ®Google Scholar
• Otterdal K, Pedersen TM, Solum NO. Release of soluble CD40 ligand after platelet activation: studies on the solubilization phase. Thromb Res 2004;114:167–177.
   PubMed Web of Science ®Google Scholar
• Marx SO, Totary-Jain H, Marks AR. Vascular smooth muscle cell proliferation in restenosis. Circ Cardiovasc Intervention 2011;4:104–111.
   PubMed Web of Science ®Google Scholar
• Zhang J, Defelice AF, Hanig JP, Colatsky T. Biomarkers of endothelial cell activation serve as potential surrogate markers for drug-induced vascular injury. Toxicol Pathol 2010;38:856–871.
   PubMed Web of Science ®Google Scholar
• O’Malley T, Ludlam CA, Riemermsa RA, Fox KA. Early increase in levels of soluble inter-cellular adhesion molecule-1 (sICAM-1); potential risk factor for the acute coronary syndromes. Eur Heart J 2001;22:1226–1234.
   PubMed Web of Science ®Google Scholar
• Vargová K, Toth-Zsámboki E, Béres BJ, Bencze J, Kerecsen G, Gulácsi-Bárdos P, Kiss RG, Préda I. Circulating endothelial cell count, plasma vWF and soluble ICAM-1 levels following primary or elective percutaneous coronary intervention. Atherosclerosis 2008;198:366–372.
   PubMed Web of Science ®Google Scholar
• Koenen RR, Weber C. Platelet-derived chemokines in vascular remodeling and atherosclerosis. Semin Thromb Hemost 2010;36:163–169.
   PubMed Web of Science ®Google Scholar
• Nagy B Jr, Miszti-Blasius K, Kerényi A, Clemetson KJ, Kappelmayer J. Potential therapeutic targeting of platelet-mediated cellular interactions in atherosclerosis and inflammation. Curr Med Chem 2012;19:518–531.
   PubMed Web of Science ®Google Scholar
• Serrano CV Jr, Ramires JA, Venturinelli M, Arie S, D’Amico E, Zweier JL, Pileggi F, da Luz PL. Coronary angioplasty results in leukocyte and platelet activation with adhesion molecule expression. Evidence of inflammatory responses in coronary angioplasty. J Am Coll Cardiol 1997;29:1276–1283.
   PubMed Web of Science ®Google Scholar
• Llano R, Winsor-Hines D, Patel DB, Seifert PS, Hamamdzic D, Wilson GJ, Wang H, Keane MG, Huibregtse BA, Wilensky RL. Vascular responses to drug-eluting and bare metal stents in diabetic/hypercholesterolemic and nonatherosclerotic porcine coronary arteries. Circ Cardiovasc Intervention 2011;4:438–446.
   PubMed Web of Science ®Google Scholar
• Wolberg AS, Aleman MM, Leiderman K, Machlus KR. Procoagulant activity in hemostasis and thrombosis: Virchow’s triad revisited. Anesth Analg 2012;114:275–285.
   PubMed Web of Science ®Google Scholar
• Hojo Y, Ikeda U, Katsuki T, Mizuno O, Fukazawa H, Kurosaki K, Fujikawa H, Shimada K. Interleukin 6 expression in coronary circulation after coronary angioplasty as a risk factor for restenosis. Heart 2000;84:83–87.
   PubMed Web of Science ®Google Scholar
• Boos CJ, Balakrishnan B, Jessani S, Blann AD, Lip GY. Effects of percutaneous coronary intervention on peripheral venous blood circulating endothelial cells and plasma indices of endothelial damage/dysfunction. Chest 2007;132:1920–1926.
   PubMed Web of Science ®Google Scholar
• Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood 1994;84:2068–2101.
   PubMed Web of Science ®Google Scholar
• Mohamed-Ali V, Armstrong L, Clarke D, Bolton CH, Pinkney JH. Evidence for the regulation of levels of plasma adhesion molecules by proinflammatory cytokines and their soluble receptors in type 1 diabetes. J Int Med 2001;250:415–421.
   PubMed Web of Science ®Google Scholar
• McNair ED, Wells CR, Mabood Qureshi A, Basran R, Pearce C, Orvold J, Devilliers J, Prasad K. Soluble receptors for advanced glycation end products (sRAGE) as a predictor of restenosis following percutaneous coronary intervention. Clin Cardiol 2010;33:678–685.
   PubMed Web of Science ®Google Scholar
• Coll-Vinent B, Vilardell C, Font C, Oristrell J, Hernández-Rodríguez J, Yagüe J, Urbano-Márquez A, Grau JM, Cid MC. Circulating soluble adhesion molecules in patients with giant cell arteritis. Correlation between soluble intercellular adhesion molecule-1 (sICAM-1) concentrations and disease activity. Ann Rheum Dis 1999;58:189–192.
   Google Scholar
• Wang ZJ, Zhou YJ, Liu YY, Yu M, Shi DM, Zhao YX, Guo YH, Cheng WJ, Jia de A, Cao Z, et al. Impact of clopidogrel resistance on thrombotic events after percutaneous coronary intervention with drug-eluting stent. Thromb Res 2009;124:46–51.
   Google Scholar
• Leé S, Vargová K, Hizoh I, Horváth Z, Gulácsi-Bárdos P, Sztupinszki Z, Apró A, Kovács A, Préda I, Tóth-Zsámboki E, et al. High on clopidogrel treatment platelet reactivity is frequent in acute and rare in elective stenting and can be functionally overcome by switch of therapy. Thromb Res 2014;133:257–264.
   PubMed Web of Science ®Google Scholar
• Sardella G, Mariani P, D’Alessandro M, De Luca L, Pierro M, Mancone M, Porretta A, Accapezzato D, Fedele F, Paroli M. Early elevation of interleukin-1beta and interleukin-6 levels after bare or drug-eluting stent implantation in patients with stable angina. Thromb Res 2006;117:659–664.
   PubMed Web of Science ®Google Scholar